Patent ID: 7235565

Claim:
A method for treating diabetes, the method comprising administering to a patient in need thereof a compound having a structure selected from the group consisting of: or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein: X is oxygen or sulfur; Y is selected from the group consisting of —NO 2 and —C(═O)OR 5 ; Z is —CH 2 — or —C(═O)—; R 1 is selected from the group consisting of C 1-10 alkyl and aryl C 1-10 alkyl, wherein R 1 is unsubstituted or substituted with at least one substituent selected from the group consisting of halogen, alkoxy, alkylamino, dialkylamino, and keto; R 2 and R 3 are independently selected from the group consisting of halogen, hydrogen, and C 1-6 alkyl; R 7 is selected from the group consisting of cyclopentyl, phenyl, pyrazolyl, thiadiazolyl, isoxazolyl, imidazolyl, pyrrolyl, indolyl, isoquinolinyl, pyridinyl, tetrahydrothiophenyl, thienyl, furyl, tetrahydrofuranyl, thiazolidinyl, pyrazinyl, pyrrolidinyl, and piperidinyl, wherein R 7 is unsubstituted or substituted with at least one substituent selected from the group consisting of halogen, alkoxy, nitro, and alkylamino; and R 5 is C 1-6 alkyl.